Evidence map›Paper›PMID 31783024›Full record

ArticleInternational journal for parasitology2020

The changing profile of schistosomiasis in a changing urban landscape.

Luciano K Silva, Lúcio M Barbosa, Jeffrey D Kovach, Rogério Dos Santos Teixeira, Ênio Silva Soares, Cristiane Wanderley Cardoso, Rosângela Vasconcelos Martins Marques, Tatiane Pereira Dos Santos, Mitermayer G Reis, Ronald E Blanton

Open access · greenAbstract read
In one paragraph

Article in International journal for parasitology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Luciano K SilvaGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Lúcio M BarbosaBahiana School of Medicine and Public Health, Salvador, Bahia, Brazil.
Jeffrey D KovachCase Western Reserve University, Department of Pathology, Cleveland, OH, USA.
Rogério Dos Santos TeixeiraMunicipal Secretariate of Health, Salvador, Bahia, Brazil.
Ênio Silva SoaresMunicipal Secretariate of Health, Salvador, Bahia, Brazil.
Cristiane Wanderley CardosoMunicipal Secretariate of Health, Salvador, Bahia, Brazil.
Rosângela Vasconcelos Martins MarquesRegional University of Bahia, (UNIRB), Salvador, Bahia, Brazil.
Tatiane Pereira Dos SantosRegional University of Bahia, (UNIRB), Salvador, Bahia, Brazil.
Mitermayer G ReisGonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil; School of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil; Yale School of Public Health, Yale University, New Haven, CT, USA.
Ronald E BlantonCase Western Reserve University, Department of Pathology, Cleveland, OH, USA. Electronic address: rblanton1@tulane.edu.
Case Western Reserve University · USUniversidade do Estado da Bahia · BREscola Bahiana de Medicina e Saúde Pública · BRFundação Oswaldo Cruz · BRUniversidade Federal da Bahia · BR

Funding

Environmental influences on urban schistosomiasis transmission and eliminationR01AI121330 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI BLANTON, RONALD E · 2017 to 2021
$2.3M
Recurrent treatment: Effect on rural and urban S. mansoni population structureR01AI069195 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BLANTON, RONALD E · 2007 to 2011
$1.8M
NIAID NIH HHS R01 AI069195NIAID NIH HHS R01 AI121330
6 · The paper itself

Abstract

Since 2007, most of humanity resides in urban areas, a trend which continues worldwide. Diseases usually associated with rural contexts are now emerging or newly recognised in cities. In the neighbourhood of São Bartolomeu in Salvador, Brazil, the prevalence of Schistosoma mansoni infection in 2011 was >20%. Following enrollment and treatment of a portion of the community, ~25% of the area underwent urban renewal. In 2015, we returned to enrol individuals who had previously participated and a cohort that had not taken part in 2011. Thus, infected individuals in one group experienced specific drug treatment plus improved living conditions and the second group only improved living conditions. Between 2011 and 2015 there were no organised treatment programs, but adequate sanitation increased from 69% to 92% coverage, household flooding decreased, and the presence of indoor toilets increased to 99% of households. Ownership of household appliances also increased significantly. The overall prevalence of schistosome infections was 6.2%. In 2015, the cohort first seen in 2011 had a higher prevalence (8.7%) than those first seen in 2015 (4.8%) and showed a few demographic differences. The 2011 cohort was older, more likely born in Salvador, less likely to have lived outside of Salvador, spent a greater percentage of their lifetime in Salvador, but more likely to have travelled. The population structure of the parasites from both cohorts underwent a marked change with similar increased component and infrapopulation differentiation and >10 fold decrease in effective population size. There was a 4-5 year shift in age-specific prevalence in 2015 for all compared with 2011. While praziquantel may have helped reduce prevalence, our evidence suggests that the structural changes and improvements in living conditions had the biggest impact on schistosomiasis in this community.

Indexed as

AdolescentAdultAnimalsBrazilChildCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedPraziquantelPrevalenceRural PopulationSanitationSchistosoma mansoniPraziquantelCommunity-wide treatmentDifferentiationEffective population sizeEliminationPopulation geneticsSanitationUrbanisation

Identifiers

PMID31783024
PMCPMC6964254
OpenAlexW2990041671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.